revers
transcriptionpolymeras
chain
reaction
rtpcr
assay
use
test
patient
key
worker
infect
caus
viru
rtpcr
test
highli
specif
probabl
fals
posit
low
fals
neg
occur
sampl
contain
insuffici
quantiti
viru
success
amplifi
detect
amount
viru
swab
like
vari
patient
sampl
locat
nasal
throat
sputum
time
infect
progress
analys
publicli
avail
data
patient
receiv
multipl
rtpcr
test
identifi
posit
least
identifi
probabl
posit
test
decreas
time
symptom
onset
throat
sampl
less
like
yield
posit
result
rel
nasal
sampl
empir
deriv
distribut
time
symptom
onset
hospitalis
allow
us
comment
like
fals
neg
rate
cohort
patient
present
test
differ
clinic
stage
estim
expect
number
fals
neg
test
group
test
individu
show
affect
time
test
final
assess
robust
estim
fals
neg
rate
probabl
fals
posit
test
work
implic
identif
infect
patient
discharg
convalesc
patient
potenti
still
infecti
current
infect
individu
identifi
success
amplif
viru
throat
andor
nasal
swab
reversetranscriptasepolymerasechainreact
rtpcr
assay
test
highli
specif
mani
reason
sensit
imperfect
inde
multipl
studi
observ
neg
rtpcr
result
least
occas
infect
individu
falseneg
result
implic
correct
diagnosi
subsequ
commun
transmiss
thu
control
initi
seri
previou
studi
describ
cohort
test
individu
ai
et
al
instanc
retrospect
consid
infect
patient
test
neg
rtpcr
initi
present
xie
et
al
similarli
consid
infect
patient
test
neg
rtpcr
initi
present
fang
et
al
found
rtpcr
abl
identifi
infect
patient
use
swab
taken
day
onset
symptom
luo
et
al
similarli
report
initi
sensit
throat
swab
secondari
contact
meanwhil
studi
patient
yang
et
al
found
lower
posit
test
rate
throat
swab
compar
nasal
swab
although
particular
studi
relat
longitudin
studi
infect
patient
data
disaggreg
per
patient
author
howev
present
sequenti
test
data
individu
patient
use
latter
type
data
characteris
probabl
falseneg
test
result
depend
number
day
onset
symptom
perform
test
affect
site
swab
taken
coupl
data
observ
distribut
day
onset
symptom
confirm
infect
rtpcr
use
bay
theorem
estim
number
falseneg
differ
cohort
test
individu
assumpt
test
assess
sensit
result
specif
test
result
implic
exist
estim
preval
likelihood
specif
individu
infect
viru
reli
sole
rtpcr
test
aim
determin
fals
neg
rate
rtpcr
test
infect
patient
three
studi
figur
shown
probabl
falseneg
test
result
depend
number
day
sinc
symptom
onset
mean
simpl
report
posit
neg
test
count
among
individu
test
underestim
true
number
posit
test
group
illustr
potenti
impact
averag
falseneg
test
rate
suppos
time
onset
symptom
test
follow
gammadistribut
demonstr
result
figur
might
affect
test
outcom
practic
result
bi
et
al
suggest
probabl
infect
individu
get
posit
rtpcr
test
given
number
day
sinc
onset
symptom
follow
gamma
distribut
shape
rate
see
figur
tabl
use
togeth
result
appli
bay
theorem
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
recov
distribut
time
onset
symptom
get
test
see
supplementari
method
end
distribut
heavier
tail
falseneg
test
probabl
increas
time
give
scenario
patient
test
earli
longtail
patient
take
long
time
test
b
show
scenario
patient
mainli
test
later
similarli
long
tail
scenario
c
repres
scenario
patient
consist
test
earli
late
thin
tail
assum
distribut
gener
repres
vari
cours
epidem
use
estim
mani
infect
individu
incorrectli
identifi
uninfect
among
group
symptomat
test
individu
test
explor
falseposit
rate
affect
estim
individu
test
distribut
test
estim
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
test
symptomat
like
violat
dataset
therefor
make
countryspecif
predict
rather
present
sensit
scale
overal
impact
account
falseneg
falseposit
test
probabl
overal
illustr
import
thing
zero
small
falseposit
test
probabl
true
number
infect
individu
among
test
substanti
larger
number
posit
test
increas
falseposit
test
probabl
start
decreas
estim
eventu
go
neg
even
quit
small
valu
falseposit
test
probabl
decreas
sever
situat
appar
preval
among
test
lower
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
test
throat
nasal
swab
rtpcr
guarante
yield
posit
result
infect
probabl
decreas
time
sinc
onset
symptom
word
longer
time
onset
symptom
suspect
case
test
like
falseneg
result
repeat
test
suspect
rtpcr
neg
infect
drastic
decreas
chanc
fail
identifi
infect
individu
method
may
alway
feasibl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
meanwhil
fail
account
possibl
falseneg
test
potenti
bias
upward
mani
exist
estim
case
infect
fatal
risk
eg
reli
perfect
sensit
among
intern
travel
hand
also
show
even
small
falseposit
test
probabl
opposit
impact
assess
true
number
infect
test
cohort
henc
bia
case
infect
fatal
risk
estim
opposit
direct
better
understand
falseposit
test
probabl
account
precis
individu
test
would
therefor
improv
qualiti
estim
reli
number
posit
test
cohort
test
individu
result
import
implic
test
strategi
present
rtpcr
test
regim
vari
significantli
countri
determin
polici
decis
test
capac
opt
rather
abl
test
larg
portion
popul
includ
asymptomat
selfisol
mild
symptom
countri
south
korea
test
thorough
distribut
test
time
crucial
mani
test
infect
time
ago
mild
asymptomat
infect
therefor
present
treatment
like
return
fals
neg
result
countri
current
mass
test
call
test
expand
popul
larg
aim
determin
mani
peopl
recent
infect
rtpcr
test
key
worker
great
import
particularli
work
vulner
group
result
suggest
may
benefit
test
indiscrimin
conduct
singl
test
someon
symptom
day
ago
nearli
fals
neg
rate
use
nasal
swab
throat
swab
mean
determin
popul
level
exposur
serolog
test
far
like
provid
accur
profil
almost
countri
test
conduct
patient
present
symptom
hospit
order
streamlin
treatment
prevent
infect
suggest
problem
fals
neg
appreci
medic
profession
present
recognis
guidelin
world
health
organis
european
centr
diseas
control
ecdc
singl
neg
test
insuffici
rule
infect
discharg
criteria
state
patient
releas
two
repeat
test
return
neg
result
earli
outbreak
doctor
use
ct
look
evid
symptomat
patient
return
neg
result
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
minimis
risk
fals
neg
also
note
rtpcr
test
return
posit
result
even
viru
inert
cultur
sampl
possibl
verifi
patient
truli
infecti
residu
viru
genet
materi
pose
risk
releas
convalesc
patient
fals
neg
test
conclus
demonstr
sensit
rtpcr
assay
detect
infect
depend
time
onset
symptom
symptomat
individu
show
nasal
swab
appear
sensit
throat
swab
absenc
test
procedur
implic
clinic
decis
treatment
decis
need
quarantin
releas
safe
commun
also
illustr
assum
fals
posit
test
probabl
neglig
count
posit
test
underestim
count
infect
individu
group
test
individu
turn
implic
estim
case
infect
fatal
risk
wider
popul
howev
falseposit
test
probabl
nonzero
valu
low
could
mean
true
preval
among
test
lower
suggest
naiv
count
posit
test
first
data
exist
abl
analys
mani
studi
cite
other
eg
longitudin
data
patient
current
second
attempt
account
possibl
differ
among
lab
perform
rtpcr
test
although
find
evid
favour
relev
enough
evid
rule
base
alon
may
also
variat
term
gene
target
rtpcr
also
abl
consid
although
hope
result
broadli
repres
may
captur
full
extent
variat
test
protocol
test
laboratori
vari
third
attempt
account
possibl
differ
among
patient
sensit
test
realiti
one
might
expect
relat
either
underli
sever
infect
least
viral
load
neither
abl
assess
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
avail
data
furthermor
data
come
symptomat
patient
could
test
less
sensit
asymptomat
individu
least
onset
symptom
therefor
unclear
baselin
test
sensit
measur
hand
recent
italian
studi
offer
evid
among
test
posit
viral
load
equival
symptomat
asymptomat
individu
show
howev
viral
load
group
equival
condit
posit
test
might
expect
probabl
posit
test
inde
link
viral
load
true
could
mani
asymptomat
infect
individu
asymptomat
immun
system
manag
check
viral
replic
earli
infect
viral
load
suffici
result
posit
test
achiev
true
howev
might
difficult
squar
appar
transmiss
potenti
asymptomat
individu
better
understand
sensit
test
asymptomat
individu
paramount
import
fourth
estim
true
number
posit
cohort
test
individu
addit
assum
distribut
time
test
infer
result
distribut
time
confirm
guangdong
bi
et
al
even
distribut
broadli
repres
countri
countri
may
consist
time
exampl
test
capac
get
stretch
time
test
may
increas
probabl
consequ
falseneg
particular
result
therefor
taken
indic
rather
authorit
furthermor
result
relat
cohort
test
individu
rather
popul
larg
say
noth
preval
viru
among
test
said
individu
hospit
test
centr
studi
know
time
test
use
conjunct
paper
assess
like
one
test
repres
falseneg
explor
arriv
time
distribut
mode
rang
day
standard
deviat
rang
discretis
arriv
time
distribut
give
proport
x
patient
cohort
test
given
day
fraction
multipli
estim
probabl
fals
neg
predict
gamm
function
f
x
singl
nasal
swab
day
sum
togeth
give
aggreg
fals
neg
rate
p
neginf
cohort
test
accord
particular
arriv
time
distribut
get
probabl
falseneg
day
apart
simpli
took
product
f
x
f
use
place
f
x
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
symptom
onset
present
data
analys
truncat
practic
impact
densiti
particular
gamma
distribut
account
point
probabl
posit
test
result
infect
individu
given
p
day
test
exactli
estim
studi
cours
p
unknown
give
us
assum
individu
test
p
mean
easili
retriev
unknown
appear
everi
term
rh
vanish
p
suppos
test
perform
number
day
symptom
onset
let
defin
unknown
true
preval
among
test
rearrang
quadrat
alpha
discov
root
first
root
allow
us
estim
true
preval
among
test
cohort
account
falseneg
test
probabl
test
day
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
realiti
howev
individu
test
differ
day
fals
neg
test
probabl
depend
make
much
harder
estim
way
one
way
done
use
distribut
time
test
calcul
averag
falseneg
test
probabl
across
test
conduct
assum
test
done
nasal
swabher
give
falseneg
test
probabl
still
appli
equat
explor
account
falseneg
falseposit
test
probabl
affect
consequ
estim
true
preval
among
test
illustr
differ
scenario
importantli
tell
us
preval
test
cohort
wider
popul
ie
noth
correct
find
test
mildasymptomat
case
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
